Background Lung function often deteriorates after bone marrow trans-
In addition to cytotoxic chemotherapy that may be toxic to the lungs, many patients receiving allogeneic transplants in particular are given total body irradiation, which may cause lung damage. Total body radiation doses of the order of 1000 cGy have been associated with increased vascular permeability, alveolar wall oedema, and alveolar protein leakage with gross loss of lung surfactant in animals,'6 and similar pathological changes have been found in man.'7 The pathological changes caused by total body irradiation at transplantation may contribute to the increased susceptibility to pulmonary infections found after bone marrow grafting. Lung function abnormalities resulting from pulmonary irradiation include reduced lung volumes and transfer factor for carbon monoxide for the first three months, with some improvement during the subsequent one to two years.' 51115 Although there have been several studies of changes in lung function after bone marrow transplantation, none has indicated whether these measurements are useful for monitoring patients' progress after transplantation and for alerting clinicians to the early development of pneumonitis. There is some evidence that patients who are investigated and treated early have a better prognosis than those presenting toms at the time to prompt further investigations and chest radiographs at these times were normal or unchanged. At the onset of pneumonitis shortness ofbreath and fever were the most frequent symptoms; abnormal signs in the chest were frequent but not universal and some patients still had a normal chest radiograph (table 3) . Most patients developed pneumonitis three to six months after transplantation. Some patients developed a second episode some months later. The time between the first noted fall in TLco and the development of pneumonitis varied from one to 32 weeks (mean (SD) 9 6 (8-1) weeks). Of 36 episodes of pneumonitis, 29 were associated with intrapulmonary infection identified by culture of bronchoalveolar lavage fluid. In 13 episodes cytomegalovirus was identified by detection of early antigenic fluorescent foci and culture.
Other organisms found were Pneumocystis carinii in two patients, fungi (Aspergillus fumigatus and Candida albicans) in seven patients, bacteria in two patients, and mixed infections in five patients.
AVERAGE DOSE OF RADIATION TO THE LUNGS
The patients who developed pneumonitis after bone marrow transplantation had in general received a higher average dose of radiation to the lungs (median 755, range 692-800 cGy) than the patients who did not develop pneumonitis (median 716, range 649-765 cGy; p = 0-002). In the pneumonitis group only three of 18 patients received less than 720 cGy radiation to the lungs, compared with 12 of 21 patients who did not progress to pneumonitis (p < 001). 
Discussion
In this study lung function measurements six weeks after transplantation were abnormal in the patients who subsequently developed pneumonitis, and they may have a role as an early indicator of pneumonitis. The abnormality in gas transfer in these patients was found six weeks after transplantation, suggesting that lung damage sustained at or around the time of transplantation is likely to play a part in the later development of pneumonitis.
Irradiation causes pneumonitis 6-12 weeks after radiotherapy and was first described by Bergonie 22 This suggests that radiation has a role in the development of pneumonitis but is not the only culprit. Radiation damage received at transplantation may therefore predispose patients to pneumonitis and may make the lungs more susceptible to infection by opportunist organisms. As most episodes of pneumonitis were associated with intrapulmonary infections, pneumonitis is unlikely to have been simply a late manifestation of radiation pneumonitis. Furthermore, the reduction in TLCO found six weeks after transplantation was unlikely to have been due to chronic low grade infection as it occurred in all patients who later developed pneumonitis, including those in whom no cause of infection was found.
Although infectious organisms are frequently found in the lungs of patients with pneumonitis, there is a growing body of evidence, both from animal and from human studies, that pneumonitis is an immunopathological condition and not simply a result of overwhelming opportunist infection.2"25 We have found aggressive humoral and cellular immune responses in the lungs of recipients of bone marrow transplants with pneumonitis2627 and possibly this immune response causes a reduction in TLCO early after transplantation as a hypersensitivity reaction following total body irradiation. This is supported by our observation that the patients who developed pneumonitis had received higher doses of radiation to the lungs than the patients who did not. Radiation may alter the expression of host antigens on cells in the lung interstitium, resulting in the enhanced cytotoxic response seen in autoimmune and graft versus host reactions28 and leading to progressive lung damage. This may be accelerated in the presence of an acute opportunist infection.
This study shows that measurements of lung function, especially of TLCO, are sensitive indices of pulmonary disease following bone marrow transplantation. There is a group of patients in whom an increased risk of pneumonitis can be predicted, and pulmonary function measurements can be used at the onset of pneumonitis as an early indication that there is a problem. The fall in TLCO usually occurs before chest radiographic abnormalities are seen and before the appearance of some clinical signs. Spirometric measurements fell significantly at the onset ofpneumonitis, making it easy to make a quick assessment of any patient complaining of breathlessness after bone marrow transplantation. Any appreciable change in the measurements should stimulate further investigation as patients with pulmonary infections associated with pneumonitis who are treated early in the course of their disease have a better chance of survival than those treated later. '8 
